We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
23 hedge funds and large institutions have $12.5M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$433K | |
| 2 | +$372K | |
| 3 | +$245K | |
| 4 |
OC
Oppenheimer & Co
New York
|
+$199K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$84.2K |
Top Sellers
| 1 | -$338K | |
| 2 | -$332K | |
| 3 | -$323K | |
| 4 |
PCM
Prelude Capital Management
New York
|
-$291K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$284K |